Lansoprazole apollo

Size: px
Start display at page:

Download "Lansoprazole apollo"

Transcription

1 Lansoprazole apollo Lansoprazole apollo Lansoprazole CAS Number : Molecular Weight : g/mol Molecular Formula : C16H14F3N3O2S Systematic (IUPAC) : 2-({[3-methyl-4-(2,2,2- trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1h-1,3- benzodiazole Type : small molecule

2 Description Lansoprazole is a proton pump inhibitor which prevents the stomach from producing acid. It is manufactured by TAP Pharmaceutical Products. Lansoprazole has been marketed for many years and is one of several PPI s available. Categories Anti-Infective Agents Anti-Infectives Anti-Ulcer Agents Enzyme Inhibitors Proton-pump Inhibitors Taxonomy Kingdom : Organic Classes Benzimidazoles Ethers Substructures Benzimidazoles Pyridines and Derivatives Ethers Halogen Derivatives Benzene and Derivatives Imidazoles Heterocyclic compounds Aromatic compounds Imines

3 Cyanamides Sulfoxides Pharmacology Indication : For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, H. pylori eradication, and prevention of gastroinetestinal bleeds with NSAID use. Pharmacodynamics : Lansoprazole, an acid protonpump inhibitor similar to omeprazole, is used as an untiulcer drug in the treatment and maintenance of healing of duodenal or gastric ulcers, erosive and reflux esophagitis, NSAID-induced ulcer, Zollinger-Ellison syndrome, and Barrett's esophagus. Lansoprozole is active against Helicobacter pylori. The plasma elimination half-life of lansoprazole does not reflect its duration of suppression of gastric acid secretion. Thus, the plasma elimination half-life is less than two hours, while the acid inhibitory effect lasts more than 24 hours. Mechanism of action : Lansoprazole belongs to a class of antisecretory compounds, the substituted benzimidazoles, that do not exhibit anticholinergic or histamine H2-receptor antagonist properties, but rather suppress gastric acid secretion by specific inhibition of the (H+,K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. Because this enzyme system is regarded as the acid (proton) pump within the parietal cell, Lansoprazole has been characterized as a gastric acid-pump inhibitor, in that it blocks the final step of acid production. This effect is dose-related and

4 leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. Absorption : The absorption of lansoprazole is rapid, with mean Cmax occurring approximately 1.7 hours after oral dosing, and relatively complete with absolute bioavailability over 80%. Protein binding : 97% Metabolism : Hepatic. Two metabolites have been identified in measurable quantities in plasma (the hydroxylated sulfinyl and sulfone derivatives of lansoprazole). These metabolites have very little or no antisecretory activity. Lansoprazole is thought to be transformed into two active species which inhibit acid secretion by (H+,K+)-ATPase within the parietal cell canaliculus, but are not present in the systemic circulation. Route of elimination : Following single-dose oral administration of PREVACID, virtually no unchanged lansoprazole was excreted in the urine. In one study, after a single oral dose of 14C-lansoprazole, approximately one-third of the administered radiation was excreted in the urine and two-thirds was recovered in the feces. This implies a significant biliary excretion of the lansoprazole metabolites. Half life 1.5 (± 1.0) hours

5 Toxicity : Symptoms of overdose include abdominal pain, nausea and diarrhea. Affected organisms : Humans and other mammals Uses Lansoprazole is used to treat a number of problems. It is a member of a class of drugs called the proton pump inhibitors, sometimes known as PPIs. It is used to reduce the amount of acid produced in the stomach. In general, this drug is used for the treatment of ulcers of the stomach and duodenum (part of the small intestine), in combination with antibiotic drugs to remove the bacteria Helicobacter pylori from the stomach, for the prevention and treatment of other conditions associated with excess production of acid in the stomach, and for the treatment and prevention of ulcers in the stomach or gut caused by non-steroidal anti-inflammatory drugs (NSAIDs). Benefits of being on this drug can include relief from gastrointestinalpain, a reduction in excess acid production in the stomach and healing of gastrointestinal ulcers. Listed below are the typical uses of lansoprazole. Ulcers of the stomach Ulcers of the gut (duodenum) Treatment or prevention of ulcers of the stomach or gut caused by non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin, ibuprofen, ketoprofen and piroxicam which are used to treat pain and inflammation Treatment of infections caused by the bacteria Helicobacter pylori which is often associated with ulcers

6 of the gut (duodenum) or ulcer-like dyspepsia (indigestion). In this condition lansoprazole is given in combination with antibiotic therapy Gastro-oesophageal reflux disease (a condition associated with the escape of acid from the stomach into the food pipe or oesophagus causing damage and inflammation) Prevention and treatment of inflammation in the food pipe (oesophagus) also known as reflux oesophagitis On occasion your doctor may prescribe this medicine to treat a condition not on the above list. Such conditions are listed below. Pain caused by indigestion or heart burn (associated with too much acid in the stomach) Zollinger-Ellison syndrome (a condition that occurs when the stomach produces too much acid) How often do I take it? Lansoprazole is available as a tablet or capsule. Lansoprazole capsules should be swallowed whole with a glass of water and not crushed or chewed. Lansoprazole orodispersible tablets should be placed on the tongue and sucked gently, at least 30 minutes before food. The tablet should then dissolve rapidly in the mouth to release small granules which you should swallow without chewing. Alternatively, the orodispersible tablets may be swallowed whole with a glass of water. If you have serious problems swallowing then your doctor may suggest that you to take the orodispersible tablets using an oral syringe. Make sure you carefully follow the administration instructions provided. If you are taking lansoprazole once a day, take it before breakfast. If you are taking lansoprazole twice a day, take the first dose in

7 the morning before breakfast and the second dose in the evening. Use this medication regularly in order to get the most benefit from it. Remember to use it at the same time each day - unless specifically told otherwise by your doctor. It may take some time before the full benefit of this drug takes effect. Certain medical conditions may require different dosage instructions as directed by your doctor. What dose? Dosage is based on your age, gender, medical condition, response to therapy, and use of certain interacting medicines. Do I need to avoid anything? Lansoprazole may cause dizziness, giddiness (vertigo), problems with your eyesight (vision) and drowsiness (somnolence). If you experience any of these symptoms whilst taking lansoprazole, do not drive or operate machinery. Consult your doctor or pharmacist for more details. When can I stop? It is important to continue taking this medication even if you feel well, unless your doctor tells you to stop. Side Effects Feeling sick (nausea) Being sick (vomiting) Pain in the stomach area (abdomen)

8 Wind (flatulence) Diarrhoea Constipation Headache General feeling of being unwell Tingling, pricking or numbness of the skin or a feeling of pins and needles (paraesthesia) Hair loss Loss of appetite Swelling of the breasts and unable to get an erection (impotence) Low mood (depression) Pain in the joints (arthralgia) Muscle pain (myalgia) Swelling of the legs or arms (peripheral oedema) Changes in number of blood cells (detected on blood testing) Fever Tiredness Restlessness Feeling confused Strange sounds or visions (hallucinations) Feeling dizzy sometimes with a spinning feeling (vertigo) Disturbed sleep Blurred vision (sight) Dry or sore mouth and changes in the way things taste Inflammation of the tongue (glossitis) Skin rash Itchy skin (pruritus) Increased sensitivity of the skin to sunlight Excessive sweating Anaemia Kidney problems

9 Pancreatitis (inflammation of the pancreas) Liver problems Candidiasis (fungal infection) If any of these persist or you consider them severe then you should inform your doctor or pharmacist. Stop taking lansoprazole immediately and tell your doctor or got to a hospital straight away if you develop any of the following symptoms: Swelling of the hands, feet, ankles, face lips or throat which may cause difficulty swallowing or breathing. You may also develop an itchy, lumpy rash (hives) or nettle rash (urticaria). These symptoms may be a sign of an allergic reaction Blistering, peeling or bleeding of the skin around the lips, nose, eyes, mouth and genitals, possibly together with flu-like symptoms and a high temperature. These symptoms may be the sign of a very rare syndrome called Stevens-Johnson syndrome Severe blistering rash possibly with severe skin peeling which leaves large areas of raw exposed skin Yellowing of your skin, whites of your eyes, tiredness and fever. This may be a sign of liver problems Tell your doctor immediately if you develop any of the following symptoms: Diarrhoea and being sick Difficulty passing water (urine) You bruise more easily or get more infections than usual Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. A serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms

10 of a serious allergic reaction include: rash, itching/swelling (especially of the face/tongue/throat), dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. Precautions Before taking lansoprazole, tell your doctor or pharmacist if you are allergic to it; or to other proton pump inhibitors (PPIs); or if you have any other allergies. This medication should not be used if you have certain medical conditions. Before using this medicine, consult your doctor or pharmacist if you have: an allergy to lansoprazole or to other proton pump inhibitors (PPIs), the rare hereditary conditions of galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption, pregnant or breast feeding Before using this medication, tell your doctor or pharmacist your medical history, especially any of the following: liver problems, an intolerance to some sugars, phenylketonuria. Before having surgery, tell your doctor or dentist that you are taking this medication. Does alcohol intake affect this drug? Lansoprazole does not appear to be affected by alcohol The elderly: lansoprazole should be used with caution in the elderly as it may be cleared from (leave) the body more slowly in the elderly than in younger patients. A lower dose may be necessary in elderly patients.

11 Pregnancy and breastfeeding - please ensure you read the detailed information below Pregnancy The safety of lansoprazole has not been established during pregnancy. It is recommended that the use of lansoprazole is avoided during pregnancy. Ask your doctor or pharmacist if you have any doubts or questions about this. It is sensible to limit use of medication during pregnancy whenever possible. However, your doctor may decide that the benefits outweigh the risks in individual circumstances and after a careful assessment of your specific health situation. If you have any doubts or concerns you are advised to discuss the medicine with your doctor or pharmacist. Breast Feeding It is not known whether lansoprazole passes into breast milk. The manufacturer therefore states that it should not be taken if you are breastfeeding. It is sensible to limit use of medication during breastfeeding whenever possible. However, your doctor may decide that the benefits outweigh the risks in individual circumstances and after a careful assessment of your specific health situation. If you have any doubts or concerns you are advised to discuss the medicine with your doctor or pharmacist. Interactions Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you

12 for them. Do not start, stop, or change the dosage of any medicine before checking with them first. This drug should not be used with the following medications because very serious, possibly fatal interactions may occur: Atazanavir (used in the treatment of HIV). Clopidogrel (used to prevent heart attacks and strokes). If you are currently using any of these medications, tell your doctor or pharmacist before starting lansoprazole. Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: Ketoconazole, itraconazole, rifampicin (used to treat infections) Digoxin (used to treat heart problems) Tracolimus (used to prevent transplant rejection) Fluvoxamine (used to treat depression and other psychiatric disease) The oral contraceptive pill Theophylline (for asthma) Phenytoin or carbamazepine (for epilepsy) Warfarin (for thinning the blood) Other medicines for indigestion or heart burn Sucralfate (used for healing ulcers) Antacids (used for heartburn) St John's wort (used to treat mild depression) This information does not contain all possible interactions. Therefore, before using lansoprazole, tell your doctor or pharmacist of all the products you use. Missed dose If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose

13 and resume your usual dosing schedule. Do not double the dose to catch up. Warning Lansoprazole should be used with caution in patients with liver disease, the elderly, patients with an intolerance to some sugars or phenylketonuria. It should not be used in women who are pregnant or breast feeding, patients with an allergy to lansoprazole or to other proton pump inhibitors (PPIs), children, liver problems, the rare hereditary conditions of galactose intolerance, Lapp lactase deficiency, or glucosegalactose malabsorption Also see list of precautions and interactions Storage Do not store above 25ºC. Do not keep in a fridge. apollo asia Division APOLLO Pharmaceuticals API Manufacturers INDIA [P] Ltd. asia Division Mr.Vipin Saxena CEO Cellular: Cellular: Direct : FAX : Wireline Purchase HELPDESK: Wireline Sales HELPDESK:

14 Wireless 24x7 HELPDESK: Blackberry Pin : 32E6500D 32E C58 apollo@hotmail.co.in Sales@apollopharma.in Export@apollopharma.in purchase@apollopharma.in Chat: MSN Hotmail:VipinrSaxena Skype NAME:VipinrSaxena Rocketmail:VipinrSaxena Google mail:vipinrsaxena BlackBerry:28415C58 Regd. Office :- 1104, Maker Chamber V, Nariman Point Mumbai, INDIA Pin: Industrial Office D-62, OIC India Oshiwara Industrial Centre, New Link Road, Goregoan West,

15 Mumbai, INDIA Pin: Manufacturing Unit Address: Plot No. 117A, Village: Chamble Near MonaTona Limited.Wada, Maharashtra, PIN : INDIA apollo@hotmail.co.in Sales@apollopharma.in Export@apollopharma.in purchase@apollopharma.in

16

17

18

IS AND WHAT IT IS USED FOR

IS AND WHAT IT IS USED FOR 08-15 Peptazol SPIMACO Lansoprazole Peptazol 15 mg, 30 mg enteric coated pellets filled in capsules Lansoprazole 1. WHAT Peptazol IS AND WHAT IT IS USED FOR The name of your medicine is Peptazol 15 mg

More information

Bromhexine apollo

Bromhexine apollo Bromhexine apollo +9191 46 950 950 Bromhexine apollo +9191 46 950 950 Bromhexine CAS Number : 3572-43-8 Molecular Weight : 376.13 g/mol Molecular Formula :C14H20Br2N2 Systematic (IUPAC) : 2,4-dibromo-6-

More information

Magnesium citrate apollo

Magnesium citrate apollo Magnesium citrate apollo +9191 46 950 950 Magnesium citrate apollo +9191 46 950 950 Magnesium citrate CAS Number : 7779-25-1 Molecular Formula : C6H6MgO7 Molecular Weight : 214.41 g/mol Systematic (IUPAC)

More information

Desmopressin Monoacetate apollo

Desmopressin Monoacetate apollo Desmopressin Monoacetate apollo +919146950950 Desmopressin Monoacetate apollo +919146950950 Desmopressin Monoacetate CAS Number : 62288-83-9 Protein binding : 50% Molecular Weight : 1069.22 g/mol Molecular

More information

Sodium valproate apollo Sodium valproate apollo Sodium valproate

Sodium valproate apollo Sodium valproate apollo Sodium valproate Sodium valproate apollo +9191 46 950 950 Sodium valproate apollo +9191 46 950 950 Sodium valproate CAS Number : 1069-66-5 Molecular Formula : C8H15NaO2 Molecular Weight : 166.20 g/mol Systematic (IUPAC)

More information

Vitamin A palmitate apollo

Vitamin A palmitate apollo Vitamin A palmitate apollo +9191 46 950 950 Vitamin A palmitate apollo +9191 46 950 950 Vitamin A palmitate CAS Number : 79-81-2 Molecular Weight : 524.96 g/mol Molecular Formula : C36H60O2 Systematic

More information

Vildagliptin apollo Vildagliptin apollo Vildagliptin apollo Vildagliptin

Vildagliptin apollo Vildagliptin apollo Vildagliptin apollo Vildagliptin Vildagliptin apollo +9191 46 950 950 Vildagliptin apollo +9191 46 950 950 Vildagliptin apollo +9191 46 950 950 Vildagliptin CAS Number : 274901-16-5 Molecular Weight : 303.39 g/mol Molecular Formula :

More information

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets RABEPRAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet

More information

Oxalic Acid apollo Oxalic Acid apollo Oxalic Acid

Oxalic Acid apollo Oxalic Acid apollo Oxalic Acid Oxalic Acid apollo +9191 46 950 950 Oxalic Acid apollo +9191 46 950 950 Oxalic Acid CAS Number : 144-62-7 Molecular Formula : C2H2O4 Molecular Weight : 90.03 g/mol Systematic (IUPAC) : ethanedioic acid

More information

Fexofenadine apollo

Fexofenadine apollo Fexofenadine apollo +9191 46 950 950 Fexofenadine apollo +9191 46 950 950 Fexofenadine CAS Number : 83799-24-0 Molecular Weight : 501.65 g/mol Molecular Formula : C32H39NO4 Systematic (IUPAC) : 2-(4-{1-hydroxy-4-[4-

More information

Atomoxetine Hydrochloride apollo

Atomoxetine Hydrochloride apollo Atomoxetine Hydrochloride apollo +9191 46 950 950 Atomoxetine Hydrochloride apollo +9191 46 950 950 Atomoxetine Hydrochloride CAS Number : 82248-59-7 Molecular Weight : 291.82 g/mol Molecular Formula :

More information

Magnesium carbonate apollo

Magnesium carbonate apollo Magnesium carbonate apollo +9191 46 950 950 Magnesium carbonate apollo +9191 46 950 950 Magnesium carbonate CAS Number : 546-93-0 Molecular Formula : MgCO3 Molecular Weight : 84.313 g/mol Systematic (IUPAC)

More information

NEXIUM INTRAVENOUS esomeprazole sodium

NEXIUM INTRAVENOUS esomeprazole sodium NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain

More information

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. PHARMACOR OMEPRAZOLE CAPSULES Omeprazole Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. It does not contain

More information

Budesonide APOLLO

Budesonide APOLLO Budesonide APOLLO 9191 46 950 950 Budesonide APOLLO 9191 46 950 950 Budesonide CAS Number : 51333-22-3 Molecular Weight : 430.534 g/mol Molecular Formula : C25H34O6 Systematic (IUPAC) : (1S,2S,4R,8S,9S,11S,12S,13R)-

More information

Package leaflet: Information for the user. Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole

Package leaflet: Information for the user. Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole Package leaflet: Information for the user Omeprazol STADA 20 mg gastro-resistant tablets Omeprazole Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole.

This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. PHARMACOR OMEPRAZOLE CAPSULES Omeprazole Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about Pharmacor Omeprazole. It does not contain

More information

Ondansetron apollo Ondansetron apollo Ondansetron

Ondansetron apollo Ondansetron apollo Ondansetron Ondansetron apollo +9191 46 950 950 Ondansetron apollo +9191 46 950 950 Ondansetron CAS Number : 99614-02-5 Molecular Formula : C18H19N3O Molecular Weight : 293.36 g/mol Systematic (IUPAC) : 9-methyl-3-[(2-methyl-1H-

More information

Cyclobenzaprine apollo

Cyclobenzaprine apollo Cyclobenzaprine apollo +9191 46 950 950 Cyclobenzaprine apollo +9191 46 950 950 Cyclobenzaprine CAS Number : 303-53-7 Molecular Formula : C20H21N Molecular Weight :275.38 g/mol Systematic (IUPAC) : dimethyl({3-[(2e)-

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES

PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES PACKAGE LEAFLET: INFORMATION FOR THE USER LANSOPRAZOLE 15MG & 30MG GASTRO-RESISTANT CAPSULES Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

Benzylpenicillin apollo Benzylpenicillin apollo Benzylpenicillin

Benzylpenicillin apollo Benzylpenicillin apollo Benzylpenicillin Benzylpenicillin apollo +9191 46 950 950 Benzylpenicillin apollo +9191 46 950 950 Benzylpenicillin CAS Number : 61-33-6 Molecular Weight : 334.4 g/mol Molecular Formula :C16H18N2O4S Systematic (IUPAC)

More information

PACKAGE LEAFLET Page 1 of 7

PACKAGE LEAFLET Page 1 of 7 PACKAGE LEAFLET Page 1 of 7 Package leaflet: Information for the user Lansoprazole 15 mg and 30 mg Gastro-resistant Capsules (lansoprazole) Read all of this leaflet carefully before you start taking this

More information

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets

RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER RANIBOS 150mg Film-coated tablets; 300mg Film-coated tablets RANITIDINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information

More information

Miglitol apollo

Miglitol apollo Miglitol apollo +9191 46 950 950 Miglitol apollo +9191 46 950 950 Miglitol CAS Number : 72432-03-2 Molecular Weight : 207.2243 g/mol Molecular Formula : C8H17NO5 Systematic (IUPAC) : (2R,3R,4R,5S)-1-(2-

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. omeprazole delayed release capsules USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. omeprazole delayed release capsules USP READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr Sandoz Omeprazole omeprazole delayed release capsules USP Read this carefully before you start taking Sandoz Omeprazole

More information

PHARMACOR OMEPRAZOLE 20mg Enteric-coated Tablets

PHARMACOR OMEPRAZOLE 20mg Enteric-coated Tablets 20mg Enteric-coated Tablets Contain the active ingredient omeprazole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about. It does not contain all of the

More information

Omeprazole generichealth Enteric-coated Tablets

Omeprazole generichealth Enteric-coated Tablets Enteric-coated Tablets contain the active ingredient omeprazole CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about. It does not contain all of the available

More information

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated

EMILOK Global. (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated EMILOK Global (omeprazole) Composition: Each capsule contains 20 mg omeprazole as enteric-coated granules. Properties: Emilok (omeprazole) belongs to the group of proton pump inhibitors, inhibits both

More information

2 What you need to know before you take Zantac

2 What you need to know before you take Zantac Package leaflet: Information for the user Zantac Tablets 150 mg and 300 mg ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Cilostazol apollo

Cilostazol apollo Cilostazol apollo +9191 46 950 950 Cilostazol apollo +9191 46 950 950 Cilostazol CAS Number : 73963-72-1 Molecular Weight : 369.46 g/mol Molecular Formula : C20H27N5O2 Systematic (IUPAC) : 6-[4-(1-cyclohexyl-1H-1,2,3,4-

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr OMEPRAZOLE Omeprazole Delayed-Release Capsules Read this carefully before you start taking OMEPRAZOLE and each time

More information

Esomeprazole RBX Tablets Esomeprazole magnesium

Esomeprazole RBX Tablets Esomeprazole magnesium Esomeprazole RBX Tablets Esomeprazole magnesium Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about ESOMEPRAZOLE RBX. It does not contain all the available

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (omeprazole delayed release capsules USP) READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr Sandoz Omeprazole (omeprazole delayed release capsules USP) Read this carefully before you start taking Sandoz Omeprazole

More information

PATIENT INFORMATION LEAFLET PEPLOC RANGE

PATIENT INFORMATION LEAFLET PEPLOC RANGE Scheduling Status: S4 Proprietary name, Strength and Pharmaceutical Form: Peploc 20 mg tablets Peploc 40 mg tablets Read all of this leaflet carefully before using PEPLOC 20 mg or 40 mg Keep this leaflet.

More information

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium

Package leaflet: Information for the user. PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium Package leaflet: Information for the user PARIET 10 mg and 20 mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains

More information

EU RISK MANAGEMENT PLAN (EU RMP)

EU RISK MANAGEMENT PLAN (EU RMP) EU RISK MANAGEMENT PLAN (EU RMP) Active substance(s) (INN or common name): Esomeprazole Pharmaco-therapeutic group (ATC Code): A02B C05 Name of Marketing Authorisation Holder or Applicant: Strength and

More information

Package leaflet: Information for the patient. Pantoprazol Orion 20 mg gastro-resistant tablets. pantoprazole

Package leaflet: Information for the patient. Pantoprazol Orion 20 mg gastro-resistant tablets. pantoprazole Package leaflet: Information for the patient Pantoprazol Orion 20 mg gastro-resistant tablets pantoprazole Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Labetalol apollo

Labetalol apollo Labetalol apollo +9191 46 950 950 Labetalol apollo +9191 46 950 950 Labetalol CAS Number : 36894-69-6 Molecular Weight : 328.40 g/mol Molecular Formula : C19H24N2O3 Systematic (IUPAC) : 2-hydroxy-5-{1-hydroxy-2-[(4-

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. OMEPRAZOLE Omeprazole Delayed-Release Capsules READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION OMEPRAZOLE Omeprazole Delayed-Release Capsules Read this carefully before you start taking OMEPRAZOLE and each time

More information

PACKAGE LEAFLET: INFORMATION OFR THE USER. Spezato 20mg, gastro-resistant capsules, hard Omeprazole

PACKAGE LEAFLET: INFORMATION OFR THE USER. Spezato 20mg, gastro-resistant capsules, hard Omeprazole PACKAGE LEAFLET: INFORMATION OFR THE USER Spezato 20mg, gastro-resistant capsules, hard Omeprazole Read all of this leaflet carefully before you start taking this medicine - Keep this leaflet. You may

More information

Losamel 20mg Gastro-resistant Tablets

Losamel 20mg Gastro-resistant Tablets Package leaflet: Information for the user Losamel 20mg Gastro-resistant Tablets Omeprazole Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine

PACKAGE LEAFLET Package leaflet: Information for the user. Ranitidin Actavis 150 mg and 300 mg film-coated tablets. Ranitidine PACKAGE LEAFLET Package leaflet: Information for the user Ranitidin Actavis 150 mg and 300 mg film-coated tablets Ranitidine Read all of this leaflet carefully, before you start taking this medicine because

More information

Package leaflet: Information for the user. Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium

Package leaflet: Information for the user. Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium Package leaflet: Information for the user Ulcerbrex 20 mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine)

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) PACKAGE LEAFLET INFORMATION FOR THE USER Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) Read all of this leaflet carefully before you start taking this medicine.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium

PACKAGE LEAFLET: INFORMATION FOR THE USER. ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium PACKAGE LEAFLET: INFORMATION FOR THE USER ULCERBREX 10 mg mg gastro-resistant tablets Rabeprazole sodium Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Nitazoxanide apollo

Nitazoxanide apollo Nitazoxanide apollo +9191 46 950 950 Nitazoxanide apollo +9191 46 950 950 Nitazoxanide CAS Number : 55981-09-4 Molecular Weight : 307.28 g/mol Molecular Formula : C12H9N3O5S Systematic (IUPAC) : 2-[(5-nitro-1,3-thiazol-2-yl)

More information

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR

Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) 1. WHAT LODINE SR TABLETS ARE AND WHAT THEY ARE USED FOR Patient Information Leaflet Lodine* SR Tablets 600mg (etodolac) Read all of this leaflet carefully before you start using this medicine. Keep this leaflet. You may need to read it again. If you have any

More information

ESOMEPRAZOLE APOTEX Esomeprazole magnesium dihydrate

ESOMEPRAZOLE APOTEX Esomeprazole magnesium dihydrate ESOMEPRAZOLE APOTEX Esomeprazole magnesium dihydrate Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about ESOMEPRAZOLE APOTEX. It does

More information

Pantoprazole (as sodium sesquihydrate) enteric coated tablets

Pantoprazole (as sodium sesquihydrate) enteric coated tablets SOZOL Consumer Medicine Information Pantoprazole (as sodium sesquihydrate) enteric coated tablets What is in this leaflet? This leaflet answers some common questions about SOZOL. It does not contain all

More information

Heartburn and stomach pain associated with reflux or peptic ulcer

Heartburn and stomach pain associated with reflux or peptic ulcer lansoprazole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Lansoprazole ODT GH. It does not contain all the available information. It does not take

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET Page 1 of 6 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER 1 ethambutol hydrochloride Read all of this leaflet carefully before your child starts taking this medicine

More information

PATIENT INFORMATION LEAFLET CARZIN XL

PATIENT INFORMATION LEAFLET CARZIN XL SCHEDULING STATUS: S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: 4 mg film coated tablets. Read all of this leaflet carefully before you start taking. Keep this leaflet. You may need to read it

More information

Onglyza CONSUMER MEDICINE INFORMATION

Onglyza CONSUMER MEDICINE INFORMATION What is in this leaflet Onglyza Saxagliptin 2.5 mg and 5 mg film coated tablets CONSUMER MEDICINE INFORMATION This leaflet answers some of the common questions people ask about Onglyza. It does not contain

More information

ATORIS 10, 20, 40 mg film-coated tablets

ATORIS 10, 20, 40 mg film-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER ATORIS 10, 20, 40 mg film-coated tablets ATORVASTATIN This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 800mg Tablets. Cimetidine 400mg Tablets. (Cimetidine)

PACKAGE LEAFLET INFORMATION FOR THE USER. Cimetidine 800mg Tablets. Cimetidine 400mg Tablets. (Cimetidine) PACKAGE LEAFLET INFORMATION FOR THE USER Cimetidine 200mg Tablets Cimetidine 400mg Tablets Cimetidine 800mg Tablets (Cimetidine) Read all of this leaflet carefully before you start taking this medicine

More information

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS

PATIENT INFORMATION LEAFLET POLLENTYME S AND TABS SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS (tablets) POLLENTYME S (syrup) Read all of this leaflet carefully because it contains important information

More information

Ranitidine GH ranitidine hydrochloride film-coated tablets

Ranitidine GH ranitidine hydrochloride film-coated tablets CONSUMER MEDICINE INFORMATION Ranitidine GH ranitidine hydrochloride film-coated tablets What is in this leaflet This leaflet answers some common questions about Ranitidine GH. It does not contain all

More information

Package leaflet: Information for the user. Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole

Package leaflet: Information for the user. Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole Package leaflet: Information for the user Pantoprazole Bluefish 40 mg gastro-resistant tablets pantoprazole Read all of this leaflet carefully before you start taking this medicine because it contains

More information

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET

PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET PROPOSED PATIENT INFORMATION LEAFLET FOR PHARMA DYNAMICS CLOPIDOGREL 75 mg PATIENT INFORMATION LEAFLET SCHEDULING STATUS S3 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM PHARMA DYNAMICS CLOPIDOGREL

More information

NORVASC 5 mg and 10 mg tablets

NORVASC 5 mg and 10 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER NORVASC 5 mg and 10 mg tablets AMLODIPINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which

More information

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials.

The usual dose is 40 mg daily with amoxycillin 1.5 g (750 mg b.d.) for 2 weeks. Up to 2 g/day of amoxycillin has been used in clinical trials. Name Gasec - 2 Gastrocaps Composition Gasec-20 Gastrocaps Each Gastrocaps contains: Omeprazole 20 mg (in the form of enteric-coated pellets) Properties, effects Proton Pump Inhibitor Omeprazole belongs

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole

PACKAGE LEAFLET: INFORMATION FOR THE USER. Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole PACKAGE LEAFLET: INFORMATION FOR THE USER Losec 10 mg hard capsules Losec 20 mg hard capsules Losec 40 mg hard capsules Omeprazole Read all of this leaflet carefully before you start taking this medicine.

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. omeprazole delayed release capsules USP

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. omeprazole delayed release capsules USP READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr Sandoz Omeprazole omeprazole delayed release capsules USP Read this carefully before you start taking Sandoz Omeprazole

More information

Package leaflet: Information for the user Esopral 40 mg Powder for solution for injection/infusion esomeprazole

Package leaflet: Information for the user Esopral 40 mg Powder for solution for injection/infusion esomeprazole Package leaflet: Information for the user Esopral 40 mg Powder for solution for injection/infusion esomeprazole Read all of this leaflet carefully before you are given this medicine because it contains

More information

Terry White Chemists Omeprazole Contains the active ingredient omeprazole

Terry White Chemists Omeprazole Contains the active ingredient omeprazole Terry White Chemists Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen PACKAGE LEAFLET: INFORMATION FOR THE USER EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS Ibuprofen Read all of this leaflet carefully before you start taking Easofen Max Strength Tablets because it contains

More information

PATIENT INFORMATION LEAFLET AMLOC RANGE

PATIENT INFORMATION LEAFLET AMLOC RANGE SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: AMLOC 5 mg tablets AMLOC 10 mg tablet Read all of this leaflet carefully before you start taking AMLOC. Keep this leaflet. You may need to read it

More information

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic

PRODUCT MONOGRAPH. FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION. Anti-inflammatory, Analgesic 0 PRODUCT MONOGRAPH FLOCTAFENINE Floctafenine Tablets 200 mg and 400 mg THERAPEUTIC CLASSIFICATION Anti-inflammatory, Analgesic INFORMATION FOR THE PATIENT FLOCTAFENINE, which has been prescribed to you

More information

1. What Solpadol is and what it is used for

1. What Solpadol is and what it is used for PATIENT INFORMATION LEAFLET SOLPADOL 30mg/500mg CAPLETS Codeine Phosphate and Paracetamol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

CONSUMER MEDICINE INFORMATION

CONSUMER MEDICINE INFORMATION CONSUMER MEDICINE INFORMATION HEALTH pantoprazole (as sodium sesquihydrate) 20 & 40 mg enteric coated tablets What is in this leaflet This leaflet answers some common questions about It does not contain

More information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. lansoprazole delayed-release capsule (Manufacturer s standard) READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION Pr PREVACID lansoprazole delayed-release capsule (Manufacturer s standard) Read this carefully before you start taking

More information

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol

Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Package Leaflet: Information for the User Zyloric 100 mg and 300 mg tablets allopurinol Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may need to read

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cinfalair 4 mg chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Cinfalair 4 mg chewable tablets Read all of this leaflet carefully before your child starts taking this medicine. Keep this leaflet. You may need to read it again.

More information

Controloc 40 mg is used for:

Controloc 40 mg is used for: Name Controloc 40 mg gastro-resistant tablets Pantoprazole Before you start taking this medicine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need

More information

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC.

PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: Read this entire leaflet carefully before you start taking DYNAFLOC. SCHEDULING STATUS: S4 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: DYNAFLOC 250 (tablets) DYNAFLOC 500 (tablets) DYNAFLOC 750 (tablets) Read this entire leaflet carefully before you start taking

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient Razolager 15 mg hard gastro-resistant capsules Razolager 30 mg hard gastro-resistant capsules lansoprazole Read all of this leaflet carefully before you start

More information

Package leaflet: Information for the user. Zantac Syrup ranitidine hydrochloride

Package leaflet: Information for the user. Zantac Syrup ranitidine hydrochloride Package leaflet: Information for the user Zantac Syrup ranitidine hydrochloride Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

More information

SULFASALAZIN 500mg enteric-coated tablets

SULFASALAZIN 500mg enteric-coated tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SULFASALAZIN 500mg enteric-coated tablets SULFASALAZINE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a

More information

What pantoprazole is used for

What pantoprazole is used for CONSUMER MEDICINE INFORMATION sesquihydrate) 20 & 40 mg enteric coated tablets What is in this leaflet This leaflet answers some common questions about It does not contain all the available information.

More information

If you have any concerns about taking this medicine, ask your doctor or pharmacist.

If you have any concerns about taking this medicine, ask your doctor or pharmacist. SALPRAZ pantoprazole Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about SALPRAZ. It does not contain all the available information. It does not take

More information

Rabeprazole Clonmel 10mg Gastro-resistant Tablets Rabeprazole Clonmel 20mg Gastro-resistant Tablets

Rabeprazole Clonmel 10mg Gastro-resistant Tablets Rabeprazole Clonmel 20mg Gastro-resistant Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Rabeprazole Clonmel 10mg Gastro-resistant Tablets Rabeprazole Clonmel 20mg Gastro-resistant Tablets Rabeprazole sodium Read all of this leaflet carefully before

More information

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS

POLLENTYME S and Tabs Pharma Dynamics (Pty) Ltd Version: July 2017 (G1639) Word copy of G1639 PATIENT INFORMATION LEAFLET FOR POLLENTYME S AND TABS PROPOSED FINAL PATIENT INFORMATION LEAFLET FOR POLLENTYME TABLETS & POLLENTYME S PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S1 PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM: POLLENTYME TABLETS

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PPM Code: E1981 PATIENT INFORMATION LEAFLET SCHEDULING STATUS: S2 PROPRIETARY NAME DOSAGE FORM: film coated tablets Read all of this leaflet carefully because it contains important information for you.

More information

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets

PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. Pantoprazole Magnesium Enteric-Coated Tablets PART III: PATIENT MEDICATION INFORMATION READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE Pr PANTOPRAZOLE T Pantoprazole Magnesium Enteric-Coated Tablets Read this carefully before you start taking

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoton FasTab* 15 mg oro-dispersible tablets Zoton FasTab* 30 mg oro-dispersible tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoton FasTab* 15 mg oro-dispersible tablets Zoton FasTab* 30 mg oro-dispersible tablets. PACKAGE LEAFLET: INFORMATION FOR THE USER Zoton FasTab* 15 mg oro-dispersible tablets Zoton FasTab* 30 mg oro-dispersible tablets lansoprazole Read all of this leaflet carefully before you start taking

More information

Package leaflet: Information for the user. Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine

Package leaflet: Information for the user. Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine Sandoz Business use only Page 1 of 9 PACKAGE LEAFLET Package leaflet: Information for the user Ranitidine Sandoz effervescent 150, 150 mg effervescent tablets Ranitidine Read all of this leaflet carefully

More information

MEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only

MEDICATION GUIDE. Rabeprazole Sodium Delayed-Release Tablets Rx Only MEDICATION GUIDE Rabeprazole Sodium Delayed-Release Tablets Rx Only Read the Medication Guide that comes with rabeprazole sodium delayed-release tablets before you start taking it and each time you get

More information

Package leaflet: Information for the user. Nexium IV 40 mg Powder for solution for injection/infusion esomeprazole

Package leaflet: Information for the user. Nexium IV 40 mg Powder for solution for injection/infusion esomeprazole Package leaflet: Information for the user Nexium IV 40 mg Powder for solution for injection/infusion esomeprazole Read all of this leaflet carefully before you are given this medicine because it contains

More information

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium)

Package leaflet: Information for the user. Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) PACKAGE LEAFLET Package leaflet: Information for the user Pravastatin Actavis 20 mg and 40 mg tablets (pravastatin sodium) Read all of this leaflet carefully before you start taking this medicine because

More information

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET PATIENT INFORMATION LEAFLET CRESTOVAS (ROSUVASTATIN 5MG, 10MG, 20MG & 40MG, TABLETS USP) Please read this leaflet carefully before you start to take your medicine. It contains important information. Keep

More information

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Dexamethasone Other Names: Decadron About This Drug Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop. Possible Side Effects (More Common) Increased

More information

APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information

APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information APO-Omeprazole Contains the active ingredient omeprazole Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet carefully before taking

More information

MEDICATION GUIDE. PREVACID can have other serious side effects. See What are the possible side effects of PREVACID?

MEDICATION GUIDE. PREVACID can have other serious side effects. See What are the possible side effects of PREVACID? Page 33 of 39 MEDICATION GUIDE PREVACID (prev-a-sid) (lansoprazole) Delayed-Release Capsules and PREVACID SoluTab (prev-a-sid sol-u-tab) (lansoprazole) Delayed-Release Orally Disintegrating Tablets Read

More information

HERNOVIR 200 mg tablets

HERNOVIR 200 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER HERNOVIR 200 mg tablets ACICLOVIR This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

METHYLDOPA 250 mg Film-coated Tablets

METHYLDOPA 250 mg Film-coated Tablets PACKAGE LEAFLET: INFORMATION FOR THE USER METHYLDOPA 250 mg Film-coated Tablets METHYLDOPA This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

SINGULAIR JUNIOR 5mg chewable tablets

SINGULAIR JUNIOR 5mg chewable tablets PACKAGE LEAFLET: INFORMATION FOR THE USER SINGULAIR JUNIOR 5mg chewable tablets MONTELUKAST This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine,

More information

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR

BACTRIM tablets PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1 WHAT BACTRIM IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER BACTRIM tablets CO-TRIMOXAZOLE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information